Your browser doesn't support javascript.
loading
An Immunogenetic Signature of Ongoing Antigen Interactions in Splenic Marginal Zone Lymphoma Expressing IGHV1-2*04 Receptors.
Bikos, Vasilis; Karypidou, Maria; Stalika, Evangelia; Baliakas, Panagiotis; Xochelli, Aliki; Sutton, Lesley-Ann; Papadopoulos, George; Agathangelidis, Andreas; Papadopoulou, Evdoxia; Davis, Zadie; Algara, Patricia; Kanellis, George; Traverse-Glehen, Alexandra; Mollejo, Manuela; Anagnostopoulos, Achilles; Ponzoni, Maurilio; Gonzalez, David; Pospisilova, Sarka; Matutes, Estella; Piris, Miguel Angel; Papadaki, Theodora; Ghia, Paolo; Rosenquist, Richard; Oscier, David; Darzentas, Nikos; Tzovaras, Dimitrios; Belessi, Chrysoula; Hadzidimitriou, Anastasia; Stamatopoulos, Kostas.
Afiliação
  • Bikos V; Hematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece. Central European Institute of Technology, Masaryk University, Brno, Czech Republic.
  • Karypidou M; Hematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece. Institute of Applied Biosciences, CERTH, Thessaloniki, Greece.
  • Stalika E; Institute of Applied Biosciences, CERTH, Thessaloniki, Greece.
  • Baliakas P; Hematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece. Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
  • Xochelli A; Institute of Applied Biosciences, CERTH, Thessaloniki, Greece. Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
  • Sutton LA; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
  • Papadopoulos G; Information Technologies Institute, CERTH, Thessaloniki, Greece.
  • Agathangelidis A; Division of Experimental Oncology and Department of Onco-Hematology, Università Vita-Salute San Raffaele and Istituto Scientifico San Raffaele, Milan, Italy.
  • Papadopoulou E; Information Technologies Institute, CERTH, Thessaloniki, Greece.
  • Davis Z; Department of Haematology, Royal Bournemouth Hospital, Bournemouth, United Kingdom.
  • Algara P; Department of Pathology, Hospital Virgen de la Salud, Toledo, Spain.
  • Kanellis G; Hematopathology Department, Evangelismos Hospital, Athens, Greece.
  • Traverse-Glehen A; Department of Pathology and Hematology, Hospices Civils de Lyon, Universite Lyon, Lyon, France.
  • Mollejo M; Department of Pathology, Hospital Virgen de la Salud, Toledo, Spain.
  • Anagnostopoulos A; Hematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece.
  • Ponzoni M; Pathology Unit, San Raffaele Scientific Institute, Milan, Italy.
  • Gonzalez D; Section of Haemato-Oncology, Institute of Cancer Research, London, United Kingdom.
  • Pospisilova S; Central European Institute of Technology, Masaryk University, Brno, Czech Republic.
  • Matutes E; Section of Haemato-Oncology, Institute of Cancer Research, London, United Kingdom.
  • Piris MA; Hospital Universitario Marques de Valdecilla, Santander, Cantabria, Spain.
  • Papadaki T; Hematopathology Department, Evangelismos Hospital, Athens, Greece.
  • Ghia P; Division of Experimental Oncology and Department of Onco-Hematology, Università Vita-Salute San Raffaele and Istituto Scientifico San Raffaele, Milan, Italy.
  • Rosenquist R; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
  • Oscier D; Department of Haematology, Royal Bournemouth Hospital, Bournemouth, United Kingdom.
  • Darzentas N; Central European Institute of Technology, Masaryk University, Brno, Czech Republic.
  • Tzovaras D; Information Technologies Institute, CERTH, Thessaloniki, Greece.
  • Belessi C; Hematology Department, Nikea General Hospital, Pireaus, Greece.
  • Hadzidimitriou A; Institute of Applied Biosciences, CERTH, Thessaloniki, Greece. Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
  • Stamatopoulos K; Hematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece. Institute of Applied Biosciences, CERTH, Thessaloniki, Greece. Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden. kostas.stamatopoulos@gmail.com.
Clin Cancer Res ; 22(8): 2032-40, 2016 Apr 15.
Article em En | MEDLINE | ID: mdl-26647217
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Esplênicas / Receptores de Antígenos de Linfócitos B / Linfoma de Zona Marginal Tipo Células B / Alelos / Antígenos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Esplênicas / Receptores de Antígenos de Linfócitos B / Linfoma de Zona Marginal Tipo Células B / Alelos / Antígenos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article